Senate Bill No. 518, introduced by Senators Alvord and West, amends Section 427.18 of the Oklahoma medical marijuana law to enhance packaging and labeling requirements for medical marijuana products. The bill mandates that labels include specific warnings, such as the legal implications of driving under the influence of marijuana, advisories for pregnant women, and confirmation that the product has been tested for contaminants. Additionally, it prohibits any misleading statements on labels and restricts the use of imagery that may appeal to children, ensuring that packaging is child-resistant and does not target individuals under the age of 21.

The bill also outlines the responsibilities of medical marijuana dispensaries regarding the return or disposal of non-compliant products and requires the Executive Director of the Oklahoma Medical Marijuana Authority to establish minimum standards for packaging and labeling. These standards will include essential information such as THC potency and other cannabinoid levels. The act is set to take effect on November 1, 2025.

Statutes affected:
Introduced: 63-427.18
House Committee Substitute for Senate Bill: 63-427.18
Floor (House): 63-427.18
Floor (Senate): 63-427.18
Engrossed: 63-427.18
Amended And Engrossed: 63-427.18
Sub Committee OR Policy Committee Recommendations (House) Policy Committee Recommendation: 63-427.18